STELLANTIS NV (8TI.DE) Fundamental Analysis & Valuation

FRA:8TI • NL00150001Q9

Current stock price

5.844 EUR
+0.18 (+3.25%)
Last:

This 8TI.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. 8TI.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 8TI was profitable.
  • In the past year 8TI has reported a negative cash flow from operations.
  • Of the past 5 years 8TI 4 years were profitable.
  • 8TI had a positive operating cash flow in 4 of the past 5 years.
8TI.DE Yearly Net Income VS EBIT VS OCF VS FCF8TI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B -20B

1.2 Ratios

  • 8TI has a Return On Assets of -1.19%. This is in the lower half of the industry: 8TI underperforms 62.50% of its industry peers.
  • The Return On Equity of 8TI (-3.27%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROIC N/A
ROA(3y)0.12%
ROA(5y)3.53%
ROE(3y)-4.1%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
8TI.DE Yearly ROA, ROE, ROIC8TI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • 8TI has a Gross Margin of 7.74%. This is in the lower half of the industry: 8TI underperforms 75.00% of its industry peers.
  • 8TI's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for 8TI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 7.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.41%
GM growth 5Y-43.81%
8TI.DE Yearly Profit, Operating, Gross Margins8TI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. 8TI.DE Health Analysis

2.1 Basic Checks

  • 8TI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 8TI has more shares outstanding
  • The number of shares outstanding for 8TI has been increased compared to 5 years ago.
  • 8TI has a worse debt/assets ratio than last year.
8TI.DE Yearly Shares Outstanding8TI.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
8TI.DE Yearly Total Debt VS Total Assets8TI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B

2.2 Solvency

  • Based on the Altman-Z score of 1.30, we must say that 8TI is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.30, 8TI perfoms like the industry average, outperforming 56.25% of the companies in the same industry.
  • 8TI has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
  • 8TI's Debt to Equity ratio of 0.38 is fine compared to the rest of the industry. 8TI outperforms 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 1.3
ROIC/WACCN/A
WACC6.41%
8TI.DE Yearly LT Debt VS Equity VS FCF8TI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B 80B

2.3 Liquidity

  • A Current Ratio of 1.06 indicates that 8TI should not have too much problems paying its short term obligations.
  • 8TI has a Current ratio of 1.06. This is in the lower half of the industry: 8TI underperforms 68.75% of its industry peers.
  • 8TI has a Quick Ratio of 1.06. This is a bad value and indicates that 8TI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.77, 8TI is not doing good in the industry: 71.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.77
8TI.DE Yearly Current Assets VS Current Liabilites8TI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. 8TI.DE Growth Analysis

3.1 Past

  • The earnings per share for 8TI have decreased strongly by -16.56% in the last year.
  • Measured over the past years, 8TI shows a very strong growth in Earnings Per Share. The EPS has been growing by 31.54% on average per year.
  • 8TI shows a decrease in Revenue. In the last year, the revenue decreased by -2.15%.
  • The Revenue has been growing slightly by 2.93% on average over the past years.
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-13142.94%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%8.07%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.15% on average over the next years.
  • 8TI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.56% yearly.
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
8TI.DE Yearly Revenue VS Estimates8TI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B 200B
8TI.DE Yearly EPS VS Estimates8TI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. 8TI.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • 8TI is valuated cheaply with a Price/Earnings ratio of 2.19.
  • Based on the Price/Earnings ratio, 8TI is valued cheaper than 96.88% of the companies in the same industry.
  • 8TI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.50.
  • A Price/Forward Earnings ratio of 1.56 indicates a rather cheap valuation of 8TI.
  • Based on the Price/Forward Earnings ratio, 8TI is valued cheaply inside the industry as 96.88% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.67, 8TI is valued rather cheaply.
Industry RankSector Rank
PE 2.19
Fwd PE 1.56
8TI.DE Price Earnings VS Forward Price Earnings8TI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 8TI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 8TI is cheaper than 65.63% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.95
8TI.DE Per share data8TI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • A more expensive valuation may be justified as 8TI's earnings are expected to grow with 27.09% in the coming years.
PEG (NY)N/A
PEG (5Y)0.07
EPS Next 2Y18.5%
EPS Next 3Y27.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 8TI.DE Dividend Analysis

5.1 Amount

  • 8TI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

8TI.DE Fundamentals: All Metrics, Ratios and Statistics

STELLANTIS NV

FRA:8TI (3/24/2026, 7:00:00 PM)

5.844

+0.18 (+3.25%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners48.13%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap16.97B
Revenue(TTM)153.51B
Net Income(TTM)-2.39B
Analysts70.56
Price Target8.45 (44.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.68
Dividend Growth(5Y)N/A
DP-81.93%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-15.33%
PT rev (3m)-13.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-39.14%
EPS NY rev (3m)-39.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-0.19%
Valuation
Industry RankSector Rank
PE 2.19
Fwd PE 1.56
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.23
P/tB 0.73
EV/EBITDA 4.95
EPS(TTM)2.67
EY45.69%
EPS(NY)3.75
Fwd EY64.16%
FCF(TTM)-5.52
FCFYN/A
OCF(TTM)-1.9
OCFYN/A
SpS50.32
BVpS25.18
TBVpS8.03
PEG (NY)N/A
PEG (5Y)0.07
Graham Number38.89
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -3.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 7.74%
FCFM N/A
ROA(3y)0.12%
ROA(5y)3.53%
ROE(3y)-4.1%
ROE(5y)7.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.41%
GM growth 5Y-43.81%
F-Score1
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 5.91
Cap/Depr 145.84%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.77
Altman-Z 1.3
F-Score1
WACC6.41%
ROIC/WACCN/A
Cap/Depr(3y)139.68%
Cap/Depr(5y)144.78%
Cap/Sales(3y)6.13%
Cap/Sales(5y)6.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.56%
EPS 3Y32%
EPS 5Y31.54%
EPS Q2Q%-13142.94%
EPS Next Y-62.6%
EPS Next 2Y18.5%
EPS Next 3Y27.09%
EPS Next 5Y-3.15%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y0.75%
Revenue growth 5Y2.93%
Sales Q2Q%8.07%
Revenue Next Year25.31%
Revenue Next 2Y17.08%
Revenue Next 3Y17.94%
Revenue Next 5Y7.56%
EBIT growth 1Y-114.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1048.17%
EBIT Next 3Y151.99%
EBIT Next 5Y84.65%
FCF growth 1Y-767.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-139.82%
OCF growth 3YN/A
OCF growth 5YN/A

STELLANTIS NV / 8TI.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for STELLANTIS NV?

ChartMill assigns a fundamental rating of 2 / 10 to 8TI.DE.


What is the valuation status for 8TI stock?

ChartMill assigns a valuation rating of 6 / 10 to STELLANTIS NV (8TI.DE). This can be considered as Fairly Valued.


How profitable is STELLANTIS NV (8TI.DE) stock?

STELLANTIS NV (8TI.DE) has a profitability rating of 1 / 10.


What are the PE and PB ratios of STELLANTIS NV (8TI.DE) stock?

The Price/Earnings (PE) ratio for STELLANTIS NV (8TI.DE) is 2.19 and the Price/Book (PB) ratio is 0.23.


Can you provide the financial health for 8TI stock?

The financial health rating of STELLANTIS NV (8TI.DE) is 2 / 10.